Does Health-Related Quality of Life Improve for Advanced Pancreatic Cancer Patients Who Respond to Gemcitabine? Analysis of a Randomized Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)-Reference-Cited by-同舟云学术

Does Health-Related Quality of Life Improve for Advanced Pancreatic Cancer Patients Who Respond to Gemcitabine? Analysis of a Randomized Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)

Published:2012-02 Issue:2 Volume:43 Page:205-217
ISSN:0885-3924
Container-title:Journal of Pain and Symptom Management
language:en
Short-container-title:Journal of Pain and Symptom Management

Author:

Romanus Dorothy,Kindler Hedy L.,Archer Laura,Basch Ethan,Niedzwiecki Donna,Weeks Jane,Schrag Deborah

Funder

NCI, National Institutes of Health

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Neurology (clinical),General Nursing

Reference23 articles.

1. Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial;Louvet;J Clin Oncol,2005

2. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group;Moore;J Clin Oncol,2007

3. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with APC: a randomized trial;Burris;J Clin Oncol,1997

4. Quality of life assessment in advanced pancreatic adenocarcinoma: results from a phase III randomized trial;Reni;Pancreatology,2006

5. Evaluation of clinical benefit of chemotherapy in patients with upper gastrointestinal cancer;Hoffman;Acta Oncol,1998

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer;PLOS ONE;2024-04-04

2. Gemcitabine and Paclitaxel Versus Gemcitabine Alone After 5-Fluorouracil, Oxaliplatin, and Irinotecan in Metastatic Pancreatic Adenocarcinoma: A Randomized Phase III PRODIGE 65-UCGI 36-GEMPAX UNICANCER Study;Journal of Clinical Oncology;2024-03-20

3. Modeling health outcomes associated with BRCA testing and treatment strategies for patients with metastatic pancreatic cancer;Pancreatology;2024-03

4. Cost-Effectiveness Analysis of Screening for Pancreatic Cancer Among High-Risk Populations;JCO Oncology Practice;2023-12-12

5. Best analgesia control in pancreatic adenocarcinoma study: justification and feasibility of a randomised trial of early EUS-CPN versus standard care—a prospective observational study (The BAC-PAC study);BJC Reports;2023-09-18